# Grünenthal

Source: https://onco.cc/companies/gruenenthal/  
OnCo record `gruenenthal` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Grünenthal is a German pharmaceutical company founded in 1946 in Aachen. In OnCo it is the marketing authorisation holder of PecFent, a fentanyl nasal spray authorised in the EU for breakthrough pain in adults on maintenance opioids for chronic cancer pain.

## Summary

Grünenthal GmbH is a German pharmaceutical company based in Aachen, founded on 29 January 1946 (Wikidata Q153838, which also gives its website and English Wikipedia article). The EMA register names Gruenenthal GmbH as the marketing authorisation holder of PecFent (fentanyl pectin nasal spray), authorised 31 August 2010 for the management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain. It sponsors no trial recorded in OnCo.

## Fields

- Kind: Company
- Last checked: 2026-09-22
- Also known as: Gruenenthal GmbH; Grünenthal GmbH; Gruenenthal
- Tags: ctgov-sponsor; wave5-sponsor
- HQ: Aachen
- Type: pharma
- Website: https://www.grunenthal.com/

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Gr%C3%BCnenthal
- Official website: https://www.grunenthal.com/
- Wikidata Q153838: https://www.wikidata.org/wiki/Q153838
- EMA: PecFent (EPAR): https://www.ema.europa.eu/en/medicines/human/EPAR/pecfent

## Connected records

- technologies: [Cancer pain management](https://onco.cc/technologies/pain-management/)
- drugs: [Fentanyl (transmucosal, for breakthrough cancer pain)](https://onco.cc/drugs/fentanyl/)

---
JSON: https://onco.cc/api/v1/entities/gruenenthal.json